These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1906917)

  • 21. A promising pipeline of preclinical drug candidates for leishmaniasis and chronic Chagas' disease.
    Saldivia M; Lima APCA; Mottram JC
    Trends Parasitol; 2024 Mar; 40(3):211-213. PubMed ID: 38368155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies.
    Berman JD
    Rev Infect Dis; 1988; 10(3):560-86. PubMed ID: 3293160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A comparison of the cellular immune response and some aspects of its regulation in patients with American cutaneous leishmaniasis and American trypanosomiasis].
    Castés M
    Acta Cient Venez; 1986; 37(4):363-72. PubMed ID: 3122480
    [No Abstract]   [Full Text] [Related]  

  • 24. Bisphosphonate-Based Molecules as Potential New Antiparasitic Drugs.
    Branco Santos JC; de Melo JA; Maheshwari S; de Medeiros WMTQ; de Freitas Oliveira JW; Moreno CJ; Mario Amzel L; Gabelli SB; Sousa Silva M
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32503272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leishmania spp. and/or Trypanosoma cruzi diagnosis in dogs from endemic and nonendemic areas for canine visceral leishmaniasis.
    Troncarelli MZ; Camargo JB; Machado JG; Lucheis SB; Langoni H
    Vet Parasitol; 2009 Oct; 164(2-4):118-23. PubMed ID: 19625128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the molecular biology of trypanosomes and leishmaniae, and its impact on the development of methods for the diagnosis and vaccination of leishmaniasis and Chagas disease.
    O'Daly JA
    Biol Res; 1993; 26(1-2):219-24. PubMed ID: 7670534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parasitology. Drugs to combat tropical protozoan parasites.
    Gelb MH; Hol WG
    Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
    [No Abstract]   [Full Text] [Related]  

  • 28. [The therapeutic effect of allopurinol on American trypanosomiasis (Chagas disease) in CFW mice].
    Castrillón Rivera LE; García Fernández W; Pérez Gutiérrez C
    Salud Publica Mex; 1984; 26(2):146-54. PubMed ID: 6427943
    [No Abstract]   [Full Text] [Related]  

  • 29. Specific treatment for Trypanosoma cruzi: lack of efficacy of allopurinol in the human chronic phase of Chagas disease.
    Rassi A; Luquetti AO; Rassi A; Rassi GG; Rassi SG; DA Silva IG; Rassi AG
    Am J Trop Med Hyg; 2007 Jan; 76(1):58-61. PubMed ID: 17255230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa.
    Orenes Lorente S; Gómez R; Jiménez C; Cammerer S; Yardley V; de Luca-Fradley K; Croft SL; Ruiz Perez LM; Urbina J; Gonzalez Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 May; 13(10):3519-29. PubMed ID: 15848765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyrazolopyrimidine metabolism in Leishmania: an overview.
    Marr JJ
    Adv Exp Med Biol; 1984; 165 Pt A():231-7. PubMed ID: 6720385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Congenital trypanosomiasis and leishmaniasis].
    De Raadt P
    Arch Fr Pediatr; 1985 Dec; 42 Suppl 2():925-7. PubMed ID: 3938649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy.
    Santi AMM; Murta SMF
    Mem Inst Oswaldo Cruz; 2022; 117():e210401. PubMed ID: 35239945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thio- and Semicarbazones: Hope in the Search for Treatment of Leishmaniasis and Chagas Disease.
    Silva BV; Silva BNM
    Med Chem; 2017; 13(2):110-126. PubMed ID: 27629824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metal complexes as chemotherapeutic agents against tropical diseases: malaria, trypanosomiasis, and leishmaniasis.
    Sánchez-Delgado RA; Anzellotti A; Suárez L
    Met Ions Biol Syst; 2004; 41():379-419. PubMed ID: 15206123
    [No Abstract]   [Full Text] [Related]  

  • 36. Exposure to mixed asymptomatic infections with Trypanosoma cruzi, Leishmania braziliensis and Leishmania chagasi in the human population of the greater Amazon.
    Mendes DG; Lauria-Pires L; Nitz N; Lozzi SP; Nascimento RJ; Monteiro PS; Rebelo MM; Rosa Ade C; Santana JM; Teixeira AR
    Trop Med Int Health; 2007 May; 12(5):629-36. PubMed ID: 17445130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topoisomerases of kinetoplastid parasites as potential chemotherapeutic targets.
    Das A; Dasgupta A; Sengupta T; Majumder HK
    Trends Parasitol; 2004 Aug; 20(8):381-7. PubMed ID: 15246322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness.
    Khare S; Nagle AS; Biggart A; Lai YH; Liang F; Davis LC; Barnes SW; Mathison CJ; Myburgh E; Gao MY; Gillespie JR; Liu X; Tan JL; Stinson M; Rivera IC; Ballard J; Yeh V; Groessl T; Federe G; Koh HX; Venable JD; Bursulaya B; Shapiro M; Mishra PK; Spraggon G; Brock A; Mottram JC; Buckner FS; Rao SP; Wen BG; Walker JR; Tuntland T; Molteni V; Glynne RJ; Supek F
    Nature; 2016 Sep; 537(7619):229-233. PubMed ID: 27501246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biology of human pathogenic trypanosomatids: epidemiology, lifecycle and ultrastructure.
    Rodrigues JC; Godinho JL; de Souza W
    Subcell Biochem; 2014; 74():1-42. PubMed ID: 24264239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potential of phosphodiesterase inhibitors in parasitic diseases.
    Shakur Y; de Koning HP; Ke H; Kambayashi J; Seebeck T
    Handb Exp Pharmacol; 2011; (204):487-510. PubMed ID: 21695653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.